Snapshot from May 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / ADMA Biologics
Company

ADMA Biologics

Tracked across 3 events · 82 articles · First seen Apr 01, 2026 · Last active May 28, 2026

Sentiment
-63
Attention
6
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (3)
6 -80
Regulatory
ADMA Biologics Securities Fraud Investigation
ADMA Biologics is under investigation for securities fraud by Bleichmar Fonti & Auld LLP and Pomerantz LLP following a report by Culper Research. The report, published on March 24, 2026, alleges that ADMA Biologics engaged…
Impact: ADMA Biologics is being investigated for securities fraud due to alleged channel stuffing, which caused its stock to drop significantly. The company's reported 20% revenue growth in 2025 is under scrutiny.
Apr 01, 2026 · 69 articles
4 -80
Regulatory
ADMA Biologics Stock Drops on Fraud Claims
ADMA Biologics is under investigation by Bleichmar Fonti & Auld LLP for potential securities fraud. This follows a report by Culper Research on March 24, 2026, alleging that ADMA Biologics engaged in a 'channel stuffing'…
Impact: ADMA Biologics is being investigated for securities fraud due to alleged channel stuffing, which caused its stock to drop significantly. The company's reported 20% revenue growth in 2025 is under scrutiny.
May 01, 2026 · 7 articles
2 -30
Business
ADMA Biologics faces class action
Rosen Law Firm has announced an investigation into ADMA Biologics following allegations by Culper Research that ADMA Biologics engaged in channel stuffing to inflate revenue growth. These allegations, published by Investing.com on March 24, 2026,…
Impact: ADMA Biologics is facing a class action lawsuit due to allegations of issuing materially misleading business information and engaging in channel stuffing, which caused its stock to fall 16.6%.
May 08, 2026 · 6 articles
Key Actions (16)
100 ADMA Biologics stock declinedADMA Biologics Stock Drops...
100 Bleichmar Fonti & Auld LLP announced investigation ADMA BiologicsADMA Biologics Securities...
100 Lowey Dannenberg investigating ADMA BiologicsADMA Biologics Securities...
100 Rosen Law Firm announced investigation ADMA BiologicsADMA Biologics Securities...
95 ADMA Biologics induced distributor stockADMA Biologics Securities...
95 ADMA Biologics induced distributor stockADMA Biologics Stock Drops...
95 ADMA Biologics stock declinedADMA Biologics faces class action
93 ADMA Biologics stock declinedADMA Biologics Securities...
90 Culper Research published report ADMA BiologicsADMA Biologics Securities...
90 Culper Research published report ADMA BiologicsADMA Biologics Stock Drops...
90 Culper Research published report ADMA BiologicsADMA Biologics faces class action
85 ADMA Biologics reported revenue growthADMA Biologics Securities...
85 Bleichmar Fonti & Auld LLP announced investigation ADMA BiologicsADMA Biologics Stock Drops...
85 Rosen Law Firm announced investigation ADMA BiologicsADMA Biologics faces class action
70 Pomerantz LLP investigated claims ADMA BiologicsADMA Biologics Securities...
60 Cantor Fitzgerald downgraded ADMA BiologicsADMA Biologics Securities...
Relationships (2)
Culper Research target ↔ ADMA Biologics ADMA Biologics is the target of an activist short campaign by Culper Research, f
Culper Research activist ↔ ADMA Biologics Culper Research acts as an activist short seller against ADMA Biologics, publish
NEWSDESK
Track ADMA Biologics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.